© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits
aDepartment of Pharmacology, Georgetown University Medical Center, Georgetown, Washington, DC 20007, USA
bMayo Clinic, Rochester, MI, USA
cNIH, Bethesda, MD, USA
dDepartment of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA
eberts{at}georgetown.edu
* Corresponding author. Tel.: +1-202-687-1270; fax: +1-202-687-2585
Objectives: Women have longer rate-corrected QT intervals (QTc) and are at higher risk for developing life-threatening torsades de pointes ventricular arrhythmias than men, especially after taking medications that block cardiac human ether-a-go-go-related gene (HERG)-encoded K+ channels. The purpose of the present study was to determine if the male sex steroid hormone, dihydrotestosterone (DHT), influences QT intervals in orchiectomized (Orch) male rabbits. Methods: ECG and whole-cell patch-clamp analyses were employed to evaluate cardiac repolarization and K+ currents in hearts isolated from orchiectomized (Orch) male New Zealand White rabbits receiving subcutaneous sustained release pellets for either dihydrotestosterone (DHT) or placebo. The efficacy of the treatment paradigm was monitored by measuring plasma DHT concentrations before and after the treatment period (10–14 days). Results: The results show that rate- and drug-induced QT-lengthening is attenuated in hearts from DHT-treated rabbits relative to placebo-treated controls. No significant changes in QRS were observed in response to DHT, thereby indicating that DHT influences QT primarily through an effect on ventricular repolarization. In addition, hearts from DHT-treated rabbits displayed significantly less QT lengthening in response to quinidine challenge compared to placebo controls. Current densities for two important cardiac repolarizing K+ currents, IK1 and IKr, were found to be significantly increased in ventricular myocardium of DHT-treated rabbits. Further, the half-maximal voltage of activation (V1/2) for IKr was significantly shifted to more negative potentials in myocytes from DHT vs. placebo hearts (21.2±1.2 vs. 30.2±1.4 mV, respectively, n=12, P<0.001). Corresponding changes in rabbit ether-a-go-go-related gene (RERG) mRNA were not found when examined by Northern blot hybridization. Conclusions: These results suggest that the presence of male sex steroid hormones in male rabbits helps to suppress rate- and drug-induced delays in cardiac repolarization. DHT action produces increased current densities for IK1 and IKr and a left-shift in the V1/2 for IKr that could account, at least in part, for the observed QTc differences between males and females. Since little change was seen in ventricular RERG gene expression, DHT action in the heart may influence IKr via post-transcriptional and/or post-translational mechanisms.
KEYWORDS ECG; Gender; Gene expression; Hormones; K-channel; Repolarization
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. A. Wasserstrom, S. Kapur, S. Jones, T. Faruque, R. Sharma, J. E. Kelly, A. Pappas, W. Ho, A. H. Kadish, and G. L. Aistrup Characteristics of intracellular Ca2+ cycling in intact rat heart: a comparison of sex differences Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1895 - H1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Wu, K. Chen, B. Haendler, T. V. McDonald, and J.-S. Bian Stimulation of N-Terminal Truncated Isoform of Androgen Receptor Stabilizes Human Ether-a-go-go-Related Gene-Encoded Potassium Channel Protein via Activation of Extracellular Signal Regulated Kinase 1/2 Endocrinology, October 1, 2008; 149(10): 5061 - 5069. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Lujan, V. J. Kramer, and S. E. DiCarlo Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2799 - H2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Viskin Brugada Syndrome in Children: Don't Ask, Don't Tell? Circulation, April 17, 2007; 115(15): 1970 - 1972. [Full Text] [PDF] |
||||
![]() |
L. Xiao, L. Zhang, W. Han, Z. Wang, and S. Nattel Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H570 - H580. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Katchman, J. Koerner, T. Tosaka, R. L. Woosley, and S. N. Ebert Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1098 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-X. Bai, J. Kurokawa, M. Tamagawa, H. Nakaya, and T. Furukawa Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone Circulation, September 20, 2005; 112(12): 1701 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schimpf, C. Wolpert, F. Gaita, C. Giustetto, and M. Borggrefe Short QT syndrome Cardiovasc Res, August 15, 2005; 67(3): 357 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brouillette, K. Rivard, E. Lizotte, and C. Fiset Sex and strain differences in adult mouse cardiac repolarization: importance of androgens Cardiovasc Res, January 1, 2005; 65(1): 148 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tosaka, M. C. Casimiro, Q. Rong, S. Tella, M. Oh, A. N. Katchman, J. C. Pezzullo, K. Pfeifer, and S. N. Ebert Nicotine Induces a Long QT Phenotype in Kcnq1-Deficient Mouse Hearts J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 980 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V Pham Gender differences in cardiac development: are hormones at the heart of the matter? Cardiovasc Res, March 1, 2003; 57(3): 591 - 593. [Full Text] [PDF] |
||||
![]() |
A. F. James and J. C. Hancox Sex, drugs and arrhythmia: are gender differences in risk of torsades de pointes simply a matter of testosterone? Cardiovasc Res, January 1, 2003; 57(1): 1 - 4. [Full Text] [PDF] |
||||




